LIGAND PHARMACEUTICALS INC - 01 Jul 2025 SCHEDULE 13D Report for PELTHOS THERAPEUTICS INC. Common Stock, par value $0.0001 per share

Filing Manager
LIGAND PHARMACEUTICALS INC
Reporting Manager
Ligand Pharmaceuticals Incorporated
Security
PELTHOS THERAPEUTICS INC. Common Stock, par value $0.0001 per share
Shares outstanding
9.88M shares
Disclosed Ownership
4.93M shares
Ownership
49.9%
Form type
SCHEDULE 13D
Filing time
03 Jul 2025, 16:05:07 UTC
Date of event
01 Jul 2025
Next filing
10 Nov 2025
SEC
View on sec.gov

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Ligand Pharmaceuticals Incorporated 49.9% 4.93M 4.93M 0 /s/ Octavio Espinoza Octavio Espinoza, Chief Financial Officer 0000886163